San Mateo, Calif. -- Despite a down day on Wall Street, shares of San Mateo-based BioForm Medical rose nearly 7% in their trading debut on Wednesday after the developer of products used by plastic surgeons priced its initial public offering. The company expects to raise $80 million after pricing 10 million shares at $8 each, below its projected range of $9-$11. Shares of the company, trading under the symbol "BFRM" on the Nasdaq National Market, closed at $8.55. Its core product, Radiesse, is an injectable dermal filler designed to provide aesthetic improvement for patients.
http://biz.yahoo.com/prnews/071107/aqw093.html?.v=26
http://www.bioformmedical.com